Omega Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	68.44	70.62	186.48	22.95	2.27
Short-Term Investments	4.99	54.06	38.85	-	-
Cash & Short-Term Investments	73.43	124.68	225.33	22.95	2.27
Cash Growth	-41.11%	-44.67%	881.77%	909.28%	-
Accounts Receivable	6.13	0.62	0.26	-	-
Other Receivables	0.86	1.18	0.26	0.19	0.01
Receivables	6.99	1.8	0.52	0.19	0.01
Prepaid Expenses	8.74	10.18	3.3	0.78	0.28
Other Current Assets	0.73	0.93	0.14	0.08	0.1
Total Current Assets	89.88	137.59	229.29	24	2.65
Property, Plant & Equipment	114.05	7.86	3.61	3.48	2.83
Other Long-Term Assets	0.44	0.55	0.44	0.6	0.63
Total Assets	204.37	146	233.33	28.08	6.12
Accounts Payable	1.62	3.11	2.11	1.06	0.92
Accrued Expenses	8.21	13.96	9.58	3.47	1.15
Current Portion of Long-Term Debt	4	3.33	-	3	-
Current Portion of Leases	11.3	1.52	-	-	-
Other Current Liabilities	1.67	0.04	0.29	0.17	0.17
Total Current Liabilities	26.81	21.96	11.98	7.7	2.23
Long-Term Debt	14.89	16.6	19.87	8.73	11.89
Long-Term Leases	98.24	1.12	-	-	-
Other Long-Term Liabilities	6.42	0.34	0.85	1.06	1.21
Total Liabilities	146.35	40.03	32.71	17.49	15.33
Common Stock	0.06	0.05	0.05	0.01	0.02
Additional Paid-In Capital	392.61	343.61	335.15	1.59	0.84
Retained Earnings	-334.63	-237.21	-134.51	-66.23	-36.78
Comprehensive Income & Other	-0.01	-0.48	-0.06	-	-
Total Common Equity	58.02	105.97	200.63	-64.63	-35.92
Shareholders' Equity	58.02	105.97	200.63	10.6	-9.21
Total Liabilities & Equity	204.37	146	233.33	28.08	6.12
Total Debt	128.43	22.58	19.87	11.73	11.89
Net Cash (Debt)	-55	102.1	205.46	11.22	-9.62
Net Cash Growth	-	-50.31%	1731.34%	-	-
Net Cash Per Share	-1.02	2.13	9.17	2.87	-2.90
Filing Date Shares Outstanding	55.15	48.1	47.81	4.47	3.32
Total Common Shares Outstanding	55.14	48.07	47.79	4.47	3.32
Working Capital	63.08	115.63	217.3	16.3	0.43
Book Value Per Share	1.05	2.20	4.20	-14.47	-10.82
Tangible Book Value	58.02	105.97	200.63	-64.63	-35.92
Tangible Book Value Per Share	1.05	2.20	4.20	-14.47	-10.82
Machinery	9.5	7.4	6.02	4.56	3.02
Construction In Progress	0.59	0.83	0.05	0.02	-
Leasehold Improvements	1.29	1.38	1.38	1.38	1.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.